Buprenorphine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Buprenorphine and local guidelines before prescribing.
Mechanism
Partial mu-opioid agonist with high receptor affinity and long duration.
Uses
Opioid dependence maintenance and chronic pain (transdermal).
Dosing
- Buprenorphine patch | 5 micrograms/hour (7-day patch) ≈ about 12 mg oral morphine a day
Palliative: Symptoms Management
Side effects
Nausea, constipation, sedation, respiratory depression (ceiling effect), hepatitis with misuse.
Interactions
Other CNS depressants and benzodiazepines increase respiratory depression; precipitates withdrawal if started too early in full agonist users.
Contraindications and cautions
Acute respiratory depression; caution with benzodiazepines, liver disease
Monitoring
Sedation, respiratory rate, LFT
Pregnancy and breastfeeding
Specialist advice
Renal and hepatic impairment
Safe in renal impairment
Overdose and reversal
Naloxone may need high doses
Special advice
Start only when in mild withdrawal; slow-release patches change dose only after several days; naloxone supply for community settings.
More from the textbook: uses, cautions and other points
- Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
Renal: Chronic Kidney Disease - Pain - renally safe opioids (fentanyl, alfentanil, buprenorphine).
Renal: Chronic Kidney Disease - eGFR under 30: Use oxycodone at reduced doses with longer intervals, or fentanyl or alfentanil (and buprenorphine). Seek specialist advice.
Palliative: Symptoms Management - Fentanyl / buprenorphine patches | Stable pain; kidney failure; slow onset; heat increases absorption.
Palliative: Symptoms Management - What it is: Withdrawal in a baby exposed in the womb to opioids (heroin, methadone, buprenorphine), benzodiazepines, or other drugs.
Paediatrics: Neonatology - Substance misuse - opioid substitution (methadone, buprenorphine) safer than withdrawal; neonatal abstinence syndrome; safeguarding.
Obstetrics: Medical Problems
Where it is discussed in the book
- Renal: Chronic Kidney Disease (2 mentions)
- Palliative: Symptoms Management (3 mentions)
- Paediatrics: Neonatology (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Psychiatry: Alcohol, drugs and addiction (7 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (7 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (3 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (2 mentions)
- Integrated paediatrics chapter (1 mention)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- Public Health: Prevention, health promotion and behaviour change (1 mention)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)